Report: Advair sales rose despite health risks

Sales of GlaxoSmithKline's asthma drug Advair increased following asthma treatment recommendations from doctors who received money from GSK and other drugmakers, according to an investigation by MedPage Today and the Journal Sentinel. Advair can be dangerous and has been overused, according to this article. The treatment may be making users more susceptible to severe asthma attacks while easing symptoms, Dr. Shelley Salpeter said.

View Full Article in:

Milwaukee Journal Sentinel (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations